# Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.

> **NCT07209475** · PHASE4 · RECRUITING · sponsor: **Royal Biologics** · enrollment: 248 (estimated)

## Conditions studied

- Diabetic Foot Ulcer (DFU)
- Amnio-Maxx

## Interventions

- **BIOLOGICAL:** Amnio-Maxx® Dual Layer Amnion Patch
- **OTHER:** Standard of Care (Investigator Choice)

## Key facts

- **NCT ID:** NCT07209475
- **Lead sponsor:** Royal Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-14
- **Primary completion:** 2026-08-14
- **Final completion:** 2026-08-14
- **Target enrollment:** 248 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07209475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07209475, "Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07209475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*